6,7-Bis(2-Methoxyethoxy)-4(3H)-Quinazolinone CAS 179688-29-0 Erlotinib Hydrochloride Intermediate Purity>99.0% (HPLC)
Anotungamira mugadziri uye mutengesi weErlotinib Hydrochloride Intermediates
Erlotinib Hydrochloride CAS 183319-69-9
3-Ethynylaniline CAS 54060-30-9
6,7-Bis(2-Methoxyethoxy)-3H-Quinazolin-4-imwe CAS 179688-29-0
Please contact: alvin@ruifuchem.com
| Chemical Name | 6,7-Bis(2-Methoxyethoxy)-3H-Quinazolin-4-imwe |
| Mashoko anoreva zvakafanana | 6,7-Bis(2-Methoxyethoxy)-4(3H)-Quinazolinone;6,7-Bis (2-Methoxyethoxy) -3,4-Dihydroquinazolin-4-imwe;6,7-Bis(2-Methoxyethoxy) -4-Hydroxyquinazoline;6,7-Bis(2-Methoxyethoxy)-4-Quinazolinol;CP-380736 |
| Kusachena | Erlotinib Kusachena A;Erlotinib Lactam Kusachena |
| Nhamba yeCAS | 179688-29-0 |
| Nhamba yeCAT | RF2685 |
| Stock Status | MuStock, Kugadzirwa Kunokwira Kusvika Matani |
| Molecular Formula | C14H18N2O5 |
| Molecular Weight | 294.31 |
| Melting Point | 190.0 kusvika 194.0 ℃ |
| Density | 1.26±0.1 g/cm3 |
| Sensitive | Air Sensitive |
| Brand | Ruifu Chemical |
| Item | Zvinotsanangurwa |
| Chitarisiko | White kana Off-White Powder |
| Kuchena / Analysis Method | >99.0% (HPLC) |
| Melting Point | 190.0 kusvika 194.0 ℃ |
| Kurasika paKuomesa | <0.50% |
| Residue paIgnition | <0.20% |
| Kusachena kwakabatana neHPLC | |
| Kusachena Kwemunhu | <0.50% |
| Zvose Zvisina Kuchena | <1.00% |
| Heavy Metals | <10ppm |
| Infrared Spectrum | Inopindirana neChimiro |
| Test Standard | Enterprise Standard |
| Usage | Pakati peErlotinib Hydrochloride (CAS: 183319-69-9) |
Package: Bhodhoro, Aluminium foil bag, 25kg/Cardboard Drum, kana zvinoenderana nezvinodiwa nemutengi.
Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza uye unyoro
Kutenga sei?Please contact: sales@ruifuchem.com or alvin@ruifuchem.com
Makore 15 Oupenyu?Tine makore anopfuura 15 ane ruzivo mukugadzira uye kutumira kunze kwemhando dzakasiyana-siyana dzepamusoro dzemishonga yepakati kana makemikari akanaka.
Main Markets?Tengesa kumusika wepamba, North America, Europe, India, Russia, Korea, Japan, Australia, nezvimwe.
Zvakanakira?Hunhu hwepamusoro, mutengo unokwanisika, masevhisi ehunyanzvi uye rutsigiro rwehunyanzvi, kuendesa nekukurumidza.
HunhuSimbiso?Strict quality control system.Midziyo yehunyanzvi yekuongorora inosanganisira NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, nezvimwe.
Samples?Zvigadzirwa zvakawanda zvinopa mahara emahara ekuongorora kwemhando, mutengo wekutumira unofanirwa kubhadharwa nevatengi.
Factory Audit?Factory audit inogamuchirwa.Ndapota itai nguva isati yasvika.
MOQ?Hapana MOQ.Kurongeka kudiki kunogamuchirwa.
Delivery Nguva? Kana mukati me stock, mazuva matatu kutumirwa anovimbiswa.
Transportation?Ne Express (FedEx, DHL), neMhepo, neGungwa.
Zvinyorwa?Mushure mekutengesa sevhisi: COA, MOA, ROS, MSDS, nezvimwe zvinogona kupihwa.
Custom Synthesis?Inogona kupa echinyakare synthesis masevhisi kuti aenderane nezvinodiwa zvako zvekutsvagisa.
Payment Terms?Proforma invoice inozotumirwa kutanga mushure mekusimbisa kurongeka, yakavharirwa ruzivo rwedu rwebhangi.Kubhadhara neT/T (Telex Transfer), PayPal, Western Union, nezvimwe.
6,7-Bis (2-Methoxyethoxy) -3H-Quinazolin-4-one (CAS: 179688-29-0) iri pakati peErlotinib Hydrochloride (CAS: 183319-69-9).Erlotinib Hydrochlorate idiki molecule tyrosine kinase inhibitor iyo inoshanda zvakadzoreka pane epidermal growth factor receptors, hydrochloride yeerlotinib, mushonga wakanangwa nemolecular.Iyo US Chikafu neDrug Administration (FDA) yakabvumidza erlotinib (Tarceva) yakasanganiswa negemcitabine semutsetse wekutanga kurapa kwenzvimbo yepamusoro uye metastatic pancreatic cancer.Inonyanya kushandiswa seyechipiri- kana yechitatu-mutsara kurapwa kune yemuno advanced kana metstatic isiri diki cell lung cancer (NSCLC) uye sekurapa kwepancreatic cancer.Inoshandiswa se tyrosine inhibitor yeNSCLC kurapwa.Iyo diki molecular compound Erlotinib Hydrochlorate ndeye tyrosine kinase receptor inhibitor iyo inhibitor kupararira kwe tumor cell nekuvharira phosphorylation, inosunga kune intracellular catalytic domain ye tyrosine kinase mumakwikwi neATP, nokudaro ichivharira kudzika kwechiratidzo kutapurirana uye kuvharira chiitiko che tumor cell ligand inotsamira. HER-1/EGFR.
